Endothelial monocyte-activating polypeptide II, a tumor-derived cytokine that plays an important role in inflammation, apoptosis, and angiogenesis

Journal of Immunotherapy

Volumn 23, Issue 5, 2000, Pages 519-527

  Berger, A C ^a   Tang, G ^a   Alexander, H R ^a   Libutti, S K ^a  

^a Building 10 ^*  (United States)

Author keywords

Angiogenesis; Apoptosis; EMAP II; Inflammation; Tumor host relationship

Indexed keywords

CYTOKINE; ENDOTHELIAL MONOCYTE ACTIVATING POLYPEPTIDE; INTERLEUKIN 1BETA; RECOMBINANT CYTOKINE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CHEMOTAXIS; GENE THERAPY; HUMAN; IMMUNOTHERAPY; INFLAMMATION; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; TUMOR; VACCINIA VIRUS;

ANGIOGENESIS INHIBITORS; ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CYTOKINES; HUMANS; INFLAMMATION; MICE; NEOPLASM PROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; RNA-BINDING PROTEINS; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0033867284     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200009000-00002     Document Type: Article

References (37)

1. Tumoral vascularity as a prognostic factor in cancer
2. Tumor angiogenesis: Therapeutic implications
3. Induction of angiogenesis during the transition from hyperplasia to neoplasia
4. Cytokine regulation of endothelial cell function
5. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
6. A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin
7. Endothelial monocyte-activating polypeptide II: A novel tumor-derived polypeptide that activates host-response mechanisms
8. Characterization of a novel tumor-derived cytokine Endothelial-monocyte activating polypeptide II
9. A novel heterodlmeric cysteine protease is required for interleukin-1 beta processing in monocytes
10. Molecular cloning of the interleukin-1 beta converting enzyme
11. A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response
12. Human Tyrosyl-tRNA synthetase shares amino acid sequence homology with a putative cytokine
13. Two distinct cytokines released from human aminoacyl-tRNA synthetase
14. Cloning and expression of human endothelial-monocyte-activating polypeptide 2 (EMAP-2) and identification of its putative precursor
15. Endothelial-monocyte activating polypeptide II, A novel antitumor cytokine that suppresses primary and metastatic tumor growth and induces apoptosis in growing endothelial cells
16. Tumor necrosis factor (TNF)
17. Cytokines, inflammation, and brain injury: Role of tumor necrosis factor-alpha
18. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis
19. Localization of endothelial-monocyte-activating polypeptide II (EMAP), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: Expression by monocytes and activated microglial cells
20. Effects of autoantigen and dexamethasone treatment on expression of endothelial-monocyte activating polypeptide II and allograft-inflammatory factor-1 by activated macrophages and microglial cells in lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis
21. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis
22. The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death
23. Human CD14 mediates recognition and phagocytosis of apoptotic cells
24. Human CD14 mediates recognition and phagocytosis of apoptotic cells
25. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature
26. Interleukin 1 induces endothelial cell procoagulant while suppressing cellsurface anticoagulant activity
27. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1
28. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial ceils
29. In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-a is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII)
30. A novel tumor-derived mediator that sensitizes cytokine-resistant tumors to tumor necrosis factor
31. Tumor necrosis factor receptor I (p 55) is upregulated on endothelial cells by exposure to the tumor-derived cytokine endothelial monocyte activating polypeptide II (EMAP II)
32. Sensitization of tumor necrosis factor alpha (TNFa) resistant human melanoma by tumor specific in vivo transfer of the gene encoding for endothelial monocyte activating polypeptide II (EMAP-II) using recombinant vaccinia virus
33. Construction and expression in tumor ceils of a recombinant vaccinia virus encoding human interleukin-lβ
34. Endothelial-monocyte activating polypeptide (EMAP II), a novel antiangiogenic protein, suppresses tumor growth and induces apoptosis in endothelial cells
35. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro
36. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis
37. EMAP II: A modulator of neovascularization in the developing lung